MiMedx Group

MiMedx Group was incorporated on February 28, 2008. Its initial assets consisted of our HydroFix® and CollaFixTM technology platforms. On January 5, 2011, the company acquired all of the outstanding equity interests in Surgical Biologics, LLC, and subsequently consolidated the corporate offices and operating facilities in Kennesaw, Georgia. This strategic acquisition brought together amnion tissue processing technology with MiMedx®'s experienced management team and extensive distribution network in order to position the company for market opportunities across multiple areas of medicine. Surgical Biologics developed allografts and other products processed from human amniotic membrane that can be used for a wide range of medical applications, including ocular surface repair, gum repair, wound care, nerve and tendon protection, spine surgery, burn treatment, and many other types of procedures that require the repair of a patient’s integumental (native) tissue.
Marietta, US
Size (employees)
690 (est)+26%
MiMedx Group is headquartered in Marietta, US

Key People at MiMedx Group

Parker H. Petit

Parker H. Petit

CEO & Chairman
Deborah Dean

Deborah Dean

Executive Vice President
Thomas H. Hochuli

Thomas H. Hochuli

Vice President of Operations
William C. Taylor

William C. Taylor

President and Chief Operating Officer
Frank Burrows

Frank Burrows

Vice President of Corporate Strategy
Rebeccah J. C. Brown

Rebeccah J. C. Brown

Vice President of Product Development, Regulatory Affairs, and Quality Assurance

MiMedx Group Office Locations

MiMedx Group has office in Marietta
Marietta, US

MiMedx Group Metrics

MiMedx Group Summary

Market capitalization

$941.6 m

Closing share price

MiMedx Group's current market capitalization is $941.6 m.

MiMedx Group Financials

MiMedx Group's revenue is $59.2 m in FY, 2013 which is a 49.9% decrease from the previous period.
FY, 2013FY, 2014FY, 2015FY, 2016


$59.2 m$118.2 m$187.3 m$245 m

Revenue growth, %


Gross profit

$49.9 m$105.6 m$167.1 m


($2.6 m)$7.1 m$24.4 m

Net Income

($4.1 m)$6.2 m$29.4 m$12 m

Operating cash flow

$37.3 m$2.5 m($18.1 m)

MiMedx Group Market Value History

MiMedx Group Online Presence

MiMedx Group Company Life

You may also be interested in